23 February 2019
: Case report
Causes of Massive Vulvar Edema in Patients with Severe Ovarian Hyperstimulation Syndrome: A Case Report and Literature Review
Unusual clinical course, Challenging differential diagnosis, Unusual or unexpected effect of treatment, Clinical situation which can not be reproduced for ethical reasons
Vilma Kovač1ABCDE*, Milan Reljič1DG, Tina Bizjak2EDOI: 10.12659/AJCR.913149
Am J Case Rep 2019; 20:238-241
Abstract
BACKGROUND: Ovarian hyperstimulation syndrome (OHSS) is a potentially serious complication of ovulation stimulation. Modest vulvar edema is frequently seen in a severe form of OHSS; however, cases of massive bilateral vulvar edema are rare and pathogenesis is uncertain.
CASE REPORT: We report a 31-year-old patient with massive vulvar edema and severe OHSS after IVF treatment with GnRH antagonist and gonadotropins. Five days after embryo transfer, she was hospitalized because of severe clinical manifestation of OHSS and on the fifth day after admission she developed a massive bilateral vulvar edema. After conventional medical therapy of OHSS, vulvar edema spontaneously resolved.
CONCLUSIONS: Hypoproteinemia with low oncotic pressure and certain personal tissue characteristics may play the main role in the pathogenesis of massive vulvar edema in OHSS.
Keywords: Ovarian Hyperstimulation Syndrome, Pregnancy Complications, Vulva, Edema, Hypoproteinemia, Vulvar Diseases
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947344
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946589
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947316
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947693
Most Viewed Current Articles
21 Jun 2024 : Case report
100,250
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
53,680
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
36,071
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
07 Jul 2023 : Case report
24,897
DOI :10.12659/AJCR.940200
Am J Case Rep 2023; 24:e940200